Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xeris Biopharma Holdings, Inc. | Chief Scientific Officer | Common Stock | 720K | $1.35M | $1.87 | Jan 31, 2023 | Direct |
XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Common Stock | 0 | Oct 5, 2021 | Direct | ||
XERIS PHARMACEUTICALS INC | Chief Scientific Officer | Stock Option (Right to Buy) | 0 | Oct 5, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XERS | Xeris Biopharma Holdings, Inc. | Jan 31, 2023 | 1 | $0 | 4 | Feb 1, 2023 | Chief Scientific Officer |
XERS | Xeris Biopharma Holdings, Inc. | Feb 22, 2022 | 3 | -$19.4K | 4 | Feb 24, 2022 | Chief Scientific Officer |
XERS | Xeris Biopharma Holdings, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Chief Scientific Officer |
XERS | Xeris Biopharma Holdings, Inc. | Oct 5, 2021 | 8 | $0 | 4 | Oct 5, 2021 | Chief Scientific Officer |
XERS | XERIS PHARMACEUTICALS INC | Oct 5, 2021 | 8 | $0 | 4 | Oct 5, 2021 | Chief Scientific Officer |
XERS | Xeris Biopharma Holdings, Inc. | Oct 5, 2021 | 0 | $0 | 3 | Oct 5, 2021 | Chief Scientific Officer |